100 related articles for article (PubMed ID: 31002360)
1. miR‑888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
Cao JX
Oncol Rep; 2019 Jun; 41(6):3367-3376. PubMed ID: 31002360
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Xie K; Zhang K; Kong J; Wang C; Gu Y; Liang C; Jiang T; Qin N; Liu J; Guo X; Huo R; Liu M; Ma H; Dai J; Hu Z
Cancer Med; 2018 Jan; 7(1):157-166. PubMed ID: 29168346
[TBL] [Abstract][Full Text] [Related]
3. Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway.
An Y; Zhang Q; Li X; Wang Z; Li Y; Tang X
Biomed Pharmacother; 2018 Dec; 108():1845-1855. PubMed ID: 30372890
[TBL] [Abstract][Full Text] [Related]
4. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
5. miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4.
Xie S; Liu G; Huang J; Hu HB; Jiang W
J Cell Physiol; 2019 Aug; 234(8):14050-14057. PubMed ID: 30633357
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1.
Fang H; Liu Y; He Y; Jiang Y; Wei Y; Liu H; Gong Y; An G
Int J Oncol; 2019 May; 54(5):1821-1832. PubMed ID: 30864684
[TBL] [Abstract][Full Text] [Related]
7. Loss of FGL1 induces epithelial‑mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Bie F; Wang G; Qu X; Wang Y; Huang C; Wang Y; Du J
Int J Oncol; 2019 Sep; 55(3):697-707. PubMed ID: 31322182
[TBL] [Abstract][Full Text] [Related]
8. C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients.
Han M; Wang B; Zhu M; Zhang Y
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):614-621. PubMed ID: 31292940
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
10. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
11. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.
Li S; Ma J; Si Y; Cheng S; Hu M; Zhi X; Li B; Yu H; Jiang WG
Int J Oncol; 2019 May; 54(5):1747-1758. PubMed ID: 30816447
[TBL] [Abstract][Full Text] [Related]
13. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
Huang Q; Zhang Z; Liao Y; Liu C; Fan S; Wei X; Ai B; Xiong J
J Exp Clin Cancer Res; 2018 Jul; 37(1):133. PubMed ID: 29970138
[TBL] [Abstract][Full Text] [Related]
14. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
Dong HX; Wang R; Jin XY; Zeng J; Pan J
J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
[TBL] [Abstract][Full Text] [Related]
16. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
[TBL] [Abstract][Full Text] [Related]
17. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
He D; Wu Z; He J; Wang Y; Li Z; Gao S
Gene; 2019 May; 696():47-53. PubMed ID: 30771479
[TBL] [Abstract][Full Text] [Related]
19. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
20. MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2.
Yan A; Yang C; Chen Z; Li C; Cai L
Cell Physiol Biochem; 2015; 37(1):55-66. PubMed ID: 26278569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
